InFo Hämatologie + Onkologie

, Volume 22, Issue 3, pp 33–43 | Cite as

Nichtinfektiöse Komplikationen

Lungenbeteiligung bei hämatologischen Systemerkrankungen

  • Stephanie Susanne Stecher
  • Stephanie Lippl
  • Hans-Joachim StemmlerEmail author
  • Jens Schreiber
zertifizierte fortbildung


Bei Patienten mit hämatologischen Neoplasien kommt es infolge von Erkrankung und Therapie häufiger zu infektiösen Veränderungen der Lunge. Darüber hinaus kann aber auch die maligne Erkrankung selbst primär oder sekundär die Lunge beeinträchtigen — zum Beispiel als Lungeninfiltrat oder im Zusammenhang mit einer Leukostase. Lesen Sie im Folgenden, welche dieser nichtinfektiösen Veränderungen häufiger auftreten und wie diese zu behandeln sind.


  1. 1.
    Ahmed S et al. Pulmonary complications in chronic lymphocytic leukemia. Cancer. 2003;98(9):1912–7PubMedGoogle Scholar
  2. 2.
    Balikian JP, Herman PG. Non-Hodgkin lymphoma of the lungs. Radiology. 1979;132(3):569–76PubMedGoogle Scholar
  3. 3.
    Bashoura L et al. Pulmonary manifestations of Lymphoma and leukemia. Clin Chest Med. 2017;38(2):187–200PubMedGoogle Scholar
  4. 4.
    Berkman N et al. Pulmonary involvement in lymphoma. Leuk Lymphoma. 1996;20(3-4):229–37PubMedGoogle Scholar
  5. 5.
    Blom JW et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715–22PubMedGoogle Scholar
  6. 6.
    Bodey GP et al. Pulmonary complications of acute leukemia. Cancer. 1966;19(6):781–93PubMedGoogle Scholar
  7. 7.
    Bragg DG et al. Lymphoproliferative disorders of the lung: histopathology, clinical manifestations, and imaging features. AJR Am J Roentgenol. 1994;163(2):273–81PubMedGoogle Scholar
  8. 8.
    Brixey AG, Light RW. Pleural effusions due to dasatinib. Curr Opin Pulm Med. 2010;16(4):351–6PubMedGoogle Scholar
  9. 9.
    Byrd JC et al. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13(7):1800–16PubMedGoogle Scholar
  10. 10.
    Cazzadori A et al. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest. 1995;107(1):101–6PubMedGoogle Scholar
  11. 11.
    Chaulagain CP et al. Secondary pulmonary alveolar proteinosis in hematologic malignancies. Hematol Oncol Stem Cell Ther. 2014;7(4):127–35PubMedGoogle Scholar
  12. 12.
    Cheng S. Superior vena cava syndrome: a contemporary review of a historic disease. Cardiol Rev. 2009;17(1):16–23PubMedGoogle Scholar
  13. 13.
    Chung JH et al. Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy. J Thorac Imaging. 2009;24(2):115–8PubMedPubMedCentralGoogle Scholar
  14. 14.
    Ciurea-Lochel A et al. Lung infiltrations in Hodgkin lymphoma. Praxis (Bern 1994). 2001;90(31-32):1307–11Google Scholar
  15. 15.
    Cordier JF et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest. 1993;103(1):201–8PubMedGoogle Scholar
  16. 16.
    Cordonnier C et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med. 1994;149(3 Pt 1):788–94PubMedGoogle Scholar
  17. 17.
    Duwe BV et al. Tumors of the mediastinum. Chest. 2005;128(4):2893–909PubMedGoogle Scholar
  18. 18.
    Faiz SA et al. Pleural effusions in patients with acute leukemia and myelodysplastic syndrome. Leuk Lymphoma. 2013;54(2):329–35PubMedGoogle Scholar
  19. 19.
    Falanga A, Marchetti M. Anticancer treatment and thrombosis. Thromb Res. 2012;129(3):353–9PubMedGoogle Scholar
  20. 20.
    Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program. 2012;2012:571–81PubMedGoogle Scholar
  21. 21.
    Falanga A et al. Venous thromboembolism in the hematologic malignancies. Curr Opin Oncol. 2012;24(6):702–10PubMedGoogle Scholar
  22. 22.
    Fiche M et al. Primary pulmonary non-Hodgkin’s lymphomas. Histopathology. 1995;26(6):529–37PubMedGoogle Scholar
  23. 23.
    Green RJ et al. Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest. 1996;110(5):1305–16PubMedGoogle Scholar
  24. 24.
    Griese M et al. Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates. Eur Respir J. 2002;20(5):1284–91PubMedGoogle Scholar
  25. 25.
    Grosu HB et al. Endobronchial ultrasound-guided Transbronchial needle aspiration for the diagnosis and subtyping of lymphoma. Ann Am Thorac Soc. 2015;12(9):1336–44PubMedGoogle Scholar
  26. 26.
    Guilpain P et al. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases. Respiration. 2008;76(3):295–302PubMedGoogle Scholar
  27. 27.
    Hess CE et al. Pseudohypoxemia secondary to leukemia and thrombocytosis. N Engl J Med. 1979;301(7):361–3PubMedGoogle Scholar
  28. 28.
    Joseph G et al. Primary pulmonary plasmacytoma. Cancer. 1993;71(3):721–4PubMedGoogle Scholar
  29. 29.
    Kintzer JS Jr. et al. Thoracic and pulmonary abnormalities in multiple myeloma. A review of 958 cases. Arch Intern Med. 1978;138(5):727–30PubMedGoogle Scholar
  30. 30.
    Kligerman SJ et al. Primary extranodal lymphoma of the thorax. Radiol Clin North Am. 2016;54(4):673–87PubMedGoogle Scholar
  31. 31.
    Ko HM et al. Diagnosis and subclassification of lymphomas and non-neoplastic lesions involving mediastinal lymph nodes using endobronchial ultrasound-guided transbronchial needle aspiration. Diagn Cytopathol. 2013;41(12):1023–30PubMedGoogle Scholar
  32. 32.
    Koch CA et al. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc. 2003;78(10):1223–33PubMedGoogle Scholar
  33. 33.
    Le Coutre PD et al. Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials. Leukemia. 2016;30(7):1593–6PubMedPubMedCentralGoogle Scholar
  34. 34.
    Macdonald JB. Lung involvement in Hodgkin’s disease. Thorax. 1977;32(6):664–7PubMedPubMedCentralGoogle Scholar
  35. 35.
    Miller DL, Allen MS. Rare pulmonary neoplasms. Mayo Clin Proc. 1993;68(5):492–8PubMedGoogle Scholar
  36. 36.
    Moonim MT et al. Diagnosis and subtyping of de novo and relapsed mediastinal lymphomas by endobronchial ultrasound needle aspiration. Am J Respir Crit Care Med. 2013;188(10):1216–23PubMedPubMedCentralGoogle Scholar
  37. 37.
    Nanjappa S et al. Diffuse alveolar hemorrhage in acute myeloid leukemia. Cancer Control. 2016;23(3):272–7PubMedGoogle Scholar
  38. 38.
    Pastore F et al. The role of therapeutic leukapheresis in hyperleukocytotic AML. PLoS One. 2014;9(4):e95062PubMedPubMedCentralGoogle Scholar
  39. 39.
    Paydas S et al. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma. 2006;47(12):2527–41PubMedGoogle Scholar
  40. 40.
    Poletti V, Costabel U, Semenzato G (2005) Pulmonary complications in patients with hematological disorders: pathobiological bases and practical approach. Semin Respir Crit Care Med. 2005;26(5):439–44PubMedGoogle Scholar
  41. 41.
    Poletti V et al. Transbronchial lung biopsy in pulmonary sarcoidosis. Is it an evaluable method in detection of disease activity?. Chest. 1986;89(3):361–5PubMedGoogle Scholar
  42. 42.
    Poletti V et al. The lung as a target organ in patients with hematologic disorders. Haematologica. 2000;85(8):855–64PubMedGoogle Scholar
  43. 43.
    Porcel JM et al. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol. 2014;50(5):161–5PubMedGoogle Scholar
  44. 44.
    Portell CA, Sweetenham JW. Adult lymphoblastic lymphoma. Cancer J. 2012;18(5):432–8PubMedGoogle Scholar
  45. 45.
    Radin AI. Primary pulmonary Hodgkin’s disease. Cancer. 1990;65(3):550–63PubMedGoogle Scholar
  46. 46.
    Roberts AS et al. Extramedullary haematopoiesis: radiological imaging features. Clin Radiol. 2016;71(9):807–14PubMedGoogle Scholar
  47. 47.
    Ross JS, Ellman L. Leukemic infiltration of the lungs in the chemotherapeutic era. Am J Clin Pathol. 1974;61(2):235–41PubMedGoogle Scholar
  48. 48.
    Shaffer K et al. Primary mediastinal large-B-cell lymphoma: radiologic findings at presentation. AJR Am J Roentgenol. 1996;167(2):425–30PubMedGoogle Scholar
  49. 49.
    Shah NP et al. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. Am J Hematol. 2015;90(11):1060–4PubMedGoogle Scholar
  50. 50.
    Stemmler J et al. Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure. Leuk Lymphoma. 2002;43(7):1427–30PubMedGoogle Scholar
  51. 51.
    Takasugi JE et al. Intrathoracic granulocytic sarcomas. J Thorac Imaging. 1996;11(3):223–30.PubMedGoogle Scholar
  52. 52.
    Von Eiff M et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration. 1995;62(6):341–7PubMedGoogle Scholar
  53. 53.
    Von Eiff M et al. Differential cell count and lymphocyte subsets in bronchoalveolar lavage during pneumonia with and without peripheral neutropenia. Lung. 1995;173(1):25–33PubMedGoogle Scholar
  54. 54.
    Von Eiff M et al. Pulmonary fungal infections in patients with hematological malignancies—diagnostic approaches. Ann Hematol. 1995;70(3):135–41PubMedGoogle Scholar
  55. 55.
    Von Eiff M et al. Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures. Eur J Haematol. 1995;54(3):157–62PubMedGoogle Scholar
  56. 56.
    Vu K et al. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson cancer center. Cancer Med. 2015;4(1):27–35PubMedGoogle Scholar
  57. 57.
    Wang HQ, Li J. Clinicopathological features of myeloid sarcoma: Report of 39 cases and literature review. Pathol Res Pract. 2016;212(9):817–24PubMedGoogle Scholar
  58. 58.
    Wilson LD et al. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007;356(18):1862–9PubMedGoogle Scholar
  59. 59.
    Yousem SA et al. Primary pulmonary Hodgkin’s disease. A clinicopathologic study of 15 cases. Cancer. 1986;57(6):1217–24PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Stephanie Susanne Stecher
    • 1
  • Stephanie Lippl
    • 2
  • Hans-Joachim Stemmler
    • 2
    Email author
  • Jens Schreiber
    • 3
  1. 1.Medizinische Klinik und Poliklinik IILudwig-Maximilians-Universität München, Campus GroßhadernMünchenDeutschland
  2. 2.Medizinische Klinik und Poliklinik IIILudwig-Maximilians-Universität München, Campus GroßhadernMünchenDeutschland
  3. 3.Universitätsklinik für PneumologieOtto-von-Guericke-Universität MagdeburgMagdeburgDeutschland

Personalised recommendations